NGT HealthCare II

Venture Capital Active Nazareth, Israel Est. 2021
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
25
in our dataset
Rounds participated
27
Rounds led
11
Rounds' value
$43.9M
total disclosed, rounds participated
Stages
Pre-Seed, A Round, Seed

About

NGT HealthCare II is an impact venture capital fund investing and growing startup companies in the fields of biotechnology, pharma, bio-convergence, and medical device. The former fund, NGTVC invested in 23 medical innovative companies. The second fund, NGT Healthcare II invested already in 22 promising companies. NGT holds a franchise from the Authority for innovation to operate technological incubator in Nazareth. Among NGT HealthCare II partners are the Tehnion, Hadasit, IBI, Falcon Group Capital, Jacobs Investment Company, GIG Limited, A3 Investment Group, Arkin Holdings, OurCrowd, Salvador Pascual Sanchez Gijon, Imad and Reem Younis. NGT HealthCare II management has the experience and expertise in supporting medical startups from identifying breakthrough technologies through R&D, clinical trials, fund raising, all the way to presenting a valuable product to the market. The Fund has a 1,300 square meter facility in Nazareth including laboratories and three clean rooms. NGT HealthCare II's impact vision is to propel healthcare and life-saving technologies, encourage Arab society and contribute to a stronger economy and an inclusive and equitable Israeli society.

Portfolio · 25

Proventis Med
Reversible Implant for Long-Term Male Contraceptive Protection
1 round Latest: 2025-09
Anacure Medical
Innovative colorectal solution - smarter way to heal
1 round Latest: 2025-09
Intimo Medical
Novel Intrauterine Device
Led ★ 2 rounds $1.5M committed Latest: 2025-05
Crocevia Medical
Stealth Mode
1 round Latest: 2025-04
Nurami Medical
Modernizing Soft Tissue Repair
1 round $30.0M committed Latest: 2025-03
Grace Gene Therapy
Gene Therapy Treatment Solution to Parkinson’s Disease
1 round Latest: 2024-11
Xmetix
Smart Tactical Garments
1 round Latest: 2024-10
Optorhythm
Optogenetic therapy for the Treatment of Atrial Fibrillation with an Implantable Optic
1 round Latest: 2024-09
Hepacure
Peptide Therapies Targeting Fibrosis in Fatty Liver Disease
1 round Latest: 2024-09
Spinodal
Disposable Robotic Catheter Sheath
Led ★ 1 round Latest: 2024-01
IntraGel Therapeutics
Cancer Drug Delivery Platform
2 rounds $450K committed Latest: 2023-08
Emris Pharma
Preventing EGFRi skin toxicities, enhancing patient quality of life & Compliance for Cancer Patients
Led ★ 1 round Latest: 2023-05
Hemico Imaging
Medical Imaging System
Led ★ 1 round Latest: 2023-03
UB Therapeutics
Therapy for the Treatment of Multiple Myeloma
1 round $415K committed Latest: 2023-02
Orsight Pharma
Neovascular Age-Related Macular Degeneration Drug Treatment
Led ★ 1 round $2.1M committed Latest: 2023-01
NeoFlow
Endovascular Solution for Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Led ★ 1 round Latest: 2023-01
MicroSteer
Endoscopic Add-on Device for the Removal of Complex Lesions
Led ★ 1 round Latest: 2023-01
Noxon
Drug Development for Fibrotic Lung Diseases
Led ★ 1 round Latest: 2023-01
DIO TREE
Molecule for the Treatment of Ovarian Cancer
Led ★ 1 round $400K committed Latest: 2022-12
ELGAN Pharma
Neonatal Therapies
1 round Latest: 2022-08
EndoGI Medical
Advanced Gastrointestinal Solutions
1 round Latest: 2022-08
Barcode Nanotech
Target-specific nanoparticles for next generation RNA therapies
1 round Latest: 2022-08
I-Derm Pharma
First-in-Class Oral Therapy for Inflammatory Autoimmune Skin Diseases
Led ★ 1 round Latest: 2022-01
Slate Therapeutics
Redefining Relief for CRS Patients
Led ★ 1 round $1.0M committed Latest: 2022-01
Virility Medical
Skin Patch for the Treatment of Premature Ejaculation
1 round $8.0M committed Latest: 2021-02

Investment activity

Portfolio by sector

Health Tech & Life Sciences25
Aerospace, Defense & HLS1

Funds · 1

  • 2 — $92M Mar 2022

Q&A

What is NGT HealthCare II's primary investment focus?
NGT HealthCare II is an impact venture capital fund that invests in startup companies within biotechnology, pharma, bio-convergence, and medical devices.
When was NGT HealthCare II founded?
NGT HealthCare II was founded in 2021.
What investment stages does NGT HealthCare II typically target?
NGT HealthCare II invests in Pre-Seed, Seed, and A Round stages.
Which fund has NGT HealthCare II raised, and what was its size?
NGT HealthCare II raised Fund 2, which closed at $92 million in March 2022.
Can you name some of NGT HealthCare II's portfolio companies?
NGT HealthCare II's portfolio includes Nurami Medical, which raised a $43.65 million Series B.
What is the geographic focus of NGT HealthCare II's investments?
NGT HealthCare II makes both Israeli and non-Israeli investments, with its headquarters located in Nazareth, Israel.
Who are the managing partners at NGT HealthCare II?
Zohar Gendler serves as CEO & Managing Partner, and Nizar Mishael is CFO & Managing Partner at NGT HealthCare II.
What is NGT HealthCare II's broader mission?
NGT HealthCare II's impact vision is to advance healthcare and life-saving technologies, support Arab society, and contribute to a stronger, more inclusive Israeli economy.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)